China Rongtong Academy of Sciences Group

China Rongtong Academy of Sciences Group is a prominent subsidiary of the state-owned China Rongtong Asset Management Group, established to centralize and manage scientific research assets formerly affiliated with the Chinese military. The group operates as a high-tech innovation hub, focusing heavily on life sciences, biotechnology, and pharmaceutical development. Its core mission involves the translation of advanced military medical research into civilian healthcare applications, including the development of vaccines, emergency medicines, and diagnostic tools. The company oversees several specialized research institutes that contribute to national biosecurity and public health infrastructure. By bridging the gap between defense-related R&D and the commercial market, the Academy plays a critical role in China's national strategy for military-civilian integration. Its portfolio includes significant contributions to global health, such as the development of recombinant vaccines for infectious diseases.